Informing the drug development and commercialization industry Cary, N.C. – February 11, 2015 – Industry Standard Research (ISR Reports) has announced the availability of a new report titled “2015 Edition of the CRO Market Size Projections: 2012-2019.” For this report, ISR has utilized both publically available information and data obtained through its syndicated primary market research to provide a thorough, rational perspective for the clinical development services industry segmented by phase, geography, and service line. “ISR’s inaugural CRO Market Size report has been very well received in the industry. Now as we compare actual market data to the figures in our 2014 generated forecasts, we’re very pleased with the performance of our model and confident in our projections moving forward,” explained Andrew Schafer, President of ISR. “ISR’s unique access to high-quality primary market research data coupled with the top-down approach we use to segment total spend provides forecasting data that all parties interested in this industry should have.” “This top-down approach,” continues Schafer, “starts with total R&D spend, isolates development spend, narrows that to Phase I-IV spend, and ends with the market available to CROs. It is this outsourcing spend that ISR projects to grow at a compound annual growth rate of 7.4% over the next 4 years. This is a higher growth rate from the 5.5% seen from 2012 to 2015. In fact, this growth rate indicates that the CRO market will reach nearly $34B in 2019.” For more information on ISR’s “2015 Edition of the CRO Market Size Projections: 2012-2019” report, please visit ISR’s report page. As part of our mission to be the industry’s go-to source for market data, ISR provides and updates a free repository of core pharmaceutical industry metrics. For more information, visit ISR’s Core Industry Metrics.